Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Sep
17
2020
A NanoBCA Retrospective — A Conversation with Vincent Caprio [PODCAST] Bergeson & Campbell, P.C.
Sep
16
2020
Bioethics in a Pandemic: Vaccine Research and Clinical Trials Mintz
Sep
16
2020
White House Directs HHS to Model "Most-Favored-Nation" Price Caps for Part B and D Drugs McDermott Will & Emery
Sep
16
2020
Latest Update on FDA’s Software Pre-Cert Pilot Program Sheppard, Mullin, Richter & Hampton LLP
Sep
16
2020
Employee’s Request To Revise Drug Policy To Address CBD Use Was Not A Reasonable Accommodation Jackson Lewis P.C.
Sep
15
2020
Time to Act Against Chinese Parallel Import of Foreign Cosmetic Products Squire Patton Boggs (US) LLP
Sep
15
2020
When to Give Legal Rights to AIs? When They Can Dream Womble Bond Dickinson (US) LLP
Sep
15
2020
Trump Signs Executive Orders Aimed at Tying Domestic Drug Prices to Foreign Prices Mintz
Sep
14
2020
Trade Secret Protection & the COVID-19 Cure: Observations on Federal Policy-Making & Potential Impact on Biomedical Advances Sheppard, Mullin, Richter & Hampton LLP
Sep
14
2020
UK End of Transition – Moves to Provide Clarity for Industry Squire Patton Boggs (US) LLP
Sep
14
2020
FSIS Proposes to Expand Eligibility for Generic Label Approval and to Discontinue FSIS Evaluation of Voluntarily Submitted Labels That are Eligible for Generic Approval Keller and Heckman LLP
Sep
11
2020
China Continues Efforts to Ban and Limit Use of Plastic Products Keller and Heckman LLP
Sep
11
2020
What are the Requirements for Using Aluminum Foil as a Functional Barrier? Keller and Heckman LLP
Sep
11
2020
COVID-19 Weekly Newsletter: Pharma Companies Sign Vaccine Pledge, Relief Package Stalls Faegre Drinker
Sep
11
2020
California Supreme Court Clarifies Bounds of Legitimate Competition Under Tort and Antitrust Law The National Law Review's Guest Contributors
Sep
11
2020
USDA Provides Seafood Trade Relief K&L Gates
Sep
11
2020
Consumer Reports Evaluates Pesticide Residue on Fruits and Vegetables Keller and Heckman LLP
Sep
10
2020
Proposed CMS Rule Pushes Alignment Between Medicare Coverage and FDA Breakthrough Device Approvals Faegre Drinker
Sep
10
2020
USDA Announces Egg Product Inspection Modernization Effort Keller and Heckman LLP
Sep
10
2020
U.S. Department of Health and Human Services Proposes Guidelines for Hair Drug Testing Jackson Lewis P.C.
Sep
10
2020
Marijuana Legalization Update for 2020: A Primer on the Latest Medicinal and Recreational Use News Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Sep
10
2020
K&L Gates Triage: Rutledge v. Pharmaceutical Care Management Association [Podcast] K&L Gates
Sep
9
2020
USDA Reopens Comment Period on Interim Regulations for U.S. Hemp Production; Interested in 12 Topics Beveridge & Diamond PC
Sep
8
2020
Next Up on the Trump Administration’s Tariffs Radar – Produce Imports Squire Patton Boggs (US) LLP
Sep
8
2020
New Proposed Regulation Provides More Guidance and Some Relief on Prop 65 Warning Requirements for Heat Processed Foods and Acrylamide Sheppard, Mullin, Richter & Hampton LLP
Sep
8
2020
Class Action Alleges that “Smoked Almonds” are Misleadingly Advertised Keller and Heckman LLP
Sep
8
2020
XY, LLC v. Trans Ova Genetics, Inc. – Building on Illumina v. Ariosa Schwegman, Lundberg & Woessner, P.A.
Sep
4
2020
Bioethics in a Pandemic: Uncertainties in Applying the Draft Framework Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins